Chris Antypas joined the MJ team as lead pharmacy consultant within our Benefits Consulting department and brings over a decade of industry experience with him. In his role, Chris and his team work to provide value and unparalleled service to our clients while helping them navigate the complex pharmacy landscape in alignment with their unique company goals.
With over 14 years as a practicing pharmacist, Chris is responsible for supporting the development and implementation of high-quality and cost-effective strategies surrounding pharmacy, wellness, and medical care. Chris brings a diverse set of thoughts and recommendations as a result of his tenure as a clinical pharmacist, consultant, and pharmacy owner. His approach is rooted in putting the client and their employees first, making him a great fit for the MJ team and our clients.
Related Blogs
Gag Clause Prohibition and Attestation Requirement
Effective in 2020, the Consolidated Appropriations Act, 2021 (CAA) prohibits health plans and health insurance issuers from entering into contracts with health care providers, ...
Read More
HHS Releases Hardship Exemption Guidance for Catastrophic Coverage
On Sept. 4, 2025, the U.S. Department of Health and Human Services (HHS) issued guidance describing circumstances under which individuals who are enrolling in ...
Read More
U.S. Average Breach Cost Hits Record High of $10.22 Million
The average cost of a data breach in the U.S. soared to an all-time high of $10.22 million, even as the global average cost ...
Read More
The MJ Foundation Names Four Local Nonprofits in Indianapolis, Phoenix, Denver, and Nashville as New Charities of Choice
INDIANAPOLIS (Sept. 10, 2025) – The MJ Charitable Foundation (the MJ Foundation), has named four nonprofits in the Indianapolis, Phoenix, Denver, and Nashville community ...
Read More
The MJ Companies Named a 2025 Best Practices Agency
The MJ Companies retained its Best Practices status for 2025, joining an elite group of independent insurance agencies from across the United States. The ...
Read More
WHAT LOOKS LIKE A PHARMACY BENEFIT SOMETIMES ISN’T: THE J-CODE CONUNDRUM
From what I’ve seen, more than three quarters of employers are facing at least one J-code issue. And because medically administered and infused drugs ...
Read More